Showing 161-170 of 2072 results for "".
Clinical Genetic Testing for Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-genetic-testing-for-alzheimer-disease-and-related-dementias/32139/Understanding the role of genetics in neurodegenerative dementia can help guide testing and improve clinical practice.- Turf Wars: Reports From the Front Linehttps://practicalneurology.com/columns/practice-management/turf-wars-reports-from-the-front-line/31111/In the October 2007 issue of Practical Neurology, Associate Editor Zac Haughn explores the complex landscape of professional conflicts and collaborations within the field of neurology. The article delves into the "turf wars" that arise when neurologists compete with other specialists, such as pulmon
Blood-Based Biomarkers in Alzheimer Disease: Clinical Implementation and Limitations
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/blood-based-biomarkers-in-alzheimer-disease-clinical-implementation-and-limitations/32100/Although biomarkers for Alzheimer disease have the potential to improve evaluation and care, barriers to implementation remain.Patient-Reported Outcome Measures in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/patient-reported-outcome-measures-in-neuromuscular-disorders/35531/Information gleaned from patient-reported outcome measures provides valuable insights into the effects of neuromuscular disorders on function and quality of life.Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Myasthenia Gravis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis/31814/More treatments for myasthenia gravis are on the way.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.Diagnostic & Treatment Delay in Temporal Lobe Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-treatment-delay-in-temporal-lobe-epilepsy/31835/The average 20-year delay of referral to epilepsy centers can be improved.MOG Antibody Disease
https://practicalneurology.com/diseases-diagnoses/imaging-testing/mog-antibody-disease/31924/This case of myelin oligodendrocyte glycoprotein (MOG) antibody disease was unusual in that both central and peripheral demyelination were present.Movement Disorders Moment: Use of 3D Motion Capture for Kinematic Analysis in Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-use-of-3d-motion-capture-for-kinematic-analysis-in-movement-disorders/32077/The emerging technology, 3D motion capture, can improve diagnosis, clinical decision-making, and clinical trial precision in movement disorders.